Advertisement

Rheumatology International

, Volume 38, Issue 8, pp 1355–1362 | Cite as

The emerging role of cardiovascular magnetic resonance imaging in the assessment of cardiac involvement in juvenile idiopathic arthritis

  • Sophie Mavrogeni
  • Lambros Fotis
  • Loukia Koutsogeorgopoulou
  • Vasiliki Vartela
  • Vana Papaevangelou
  • Genovefa Kolovou
Review
  • 100 Downloads

Abstract

Juvenile idiopathic arthritis (JIA) is the commonest rheumatic disease in childhood and presents several subtypes according to the ILAR classification. JIA, specifically in its systemic form, may seriously damage various structures of the cardiovascular system. Other JIA phenotypes are also of interest, as cardiovascular disease (CVD) is underestimated and understudied, but chronic systemic inflammation and risk factors remained important contributors for CVD development. The currently applied non-invasive modalities, although they are important for the initial evaluation of JIA patients, frequently fail to detect the silent, subclinical forms of CVD. Cardiovascular magnetic resonance (CMR), due to its multifaceted capability in the detection of cardiovascular disease, can offer early, reproducible, non-invasive information about cardiovascular disease in JIA, allowing risk stratification and timely initiation /modification of cardiologic and anti-rheumatic treatment. However, lack of availability/expertise and high cost still hamper its application in the clinical cardio-rheumatic practice. The aim of the current article is to present an overview of CVD in JIA emphasizing the emerging role of CMR in early diagnosis and treatment follow-up of CVD in JIA patients.

Keywords

Juvenile rheumatoid arthritis Cardiac magnetic resonance Vasculitis Myocarditis Coronary artery disease Fibrosis 

Notes

Funding

This study was not funded by anyone.

Compliance with ethical standards

Conflict of interest

There is no conflict of interest for any of the authors

Research involving human participants and/or animals

N/A. It is a review study.

Informed consent

N/A. It is a review study.

References

  1. 1.
    Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:76778CrossRefGoogle Scholar
  2. 2.
    Symmons DP, Jones M, Osborne J et al (1996) Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 23:197580Google Scholar
  3. 3.
    Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:3902Google Scholar
  4. 4.
    Nigrovic PA, Raychaudhuri S, Thompson SD (2018) Review: genetics and the classification of arthritis in adults and children. Arthritis Rheumatol 70(1):7–17CrossRefPubMedGoogle Scholar
  5. 5.
    Minden K, Niewerth M, Listing J et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:2392401CrossRefGoogle Scholar
  6. 6.
    Zak M, Pedersen FK (2000) Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology 39:198–204CrossRefPubMedGoogle Scholar
  7. 7.
    Bohr AH, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Muller K (2016) Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J 14(1):3CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yeh KW, Lee CM, Chang CJ, Lin YJ, Huang JL (2014) Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment. PLoS One 9(6):e90757CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Lefèvre-Utile A, Galeotti C, Koné-Paut I (2014) Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. Jt Bone Spine 81(3):257–259CrossRefGoogle Scholar
  10. 10.
    Movva R, Brown SB, Morris DL, Figueredo VM (2013) Anakinra for myocarditis in juvenile idiopathic arthritis. Tex Heart Inst J 40(5):623–625PubMedPubMedCentralGoogle Scholar
  11. 11.
    Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M et al (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22):2793–2798CrossRefPubMedGoogle Scholar
  12. 12.
    Schultheiss HP, Kuhl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32(21):2616–2625CrossRefPubMedGoogle Scholar
  13. 13.
    Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M et al (1994) Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89(1):252–257CrossRefPubMedGoogle Scholar
  14. 14.
    Bharti BB, Kumar S, Kapoor A, Agarwal A, Mishra R, Sinha N (2004) Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis. J Postgrad Med 50(4):262–265 (discussion 266-7) PubMedGoogle Scholar
  15. 15.
    Bultink IE, Lems WF, Dijkmans BA, van Soesbergen RM, Lindeman J (2002) Severe aortic regurgitation in RF positive polyarticular JIA. Ann Rheum Dis 61(3):282–283CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Aubert S, Hayem G, Aumont MC, Brochet E, Acar C (2007) Valve repair for mitral insufficiency secondary to idiopathic juvenile polyarthritis. J Heart Valve Dis 16(3):324–327PubMedGoogle Scholar
  17. 17.
    Jiménez-Balderas FJ, García-Rubi D, Pérez-Hinojosa S, Arellano J, Yáñez P, Sanchez ML, Camargo-Coronel A, Zonana-Nacach A (2001) Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology 52(8):543–548CrossRefPubMedGoogle Scholar
  18. 18.
    Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Katsifis G, Markousis-Mavrogenis G, Kolovou G, Kitas GD (2018) Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives. Rheumatol Int 38(6):949–958CrossRefPubMedGoogle Scholar
  19. 19.
    Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417CrossRefPubMedGoogle Scholar
  20. 20.
    Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:32531Google Scholar
  21. 21.
    Shen CC, Yao TC, Yeh KW, Huang JL (2013) Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: a prospective study. Semin Arthritis Rheum 42(6):590–596CrossRefPubMedGoogle Scholar
  22. 22.
    Coulson EJ, Ng WF, Goff I, Foster HE (2013) Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology 52(7):1163–1171CrossRefPubMedGoogle Scholar
  23. 23.
    Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, Stavropoulos E, Spiliotis G, Sfendouraki E, Panopoulos S, Bournia V, Kolovou G, Kitas GD (2014) Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken) 66:104–112CrossRefGoogle Scholar
  24. 24.
    Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V, Kolovou G (2017) Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases. Int J Cardiol 236:151–156CrossRefPubMedGoogle Scholar
  25. 25.
    Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, Van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntman V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, Van Rossum A, Rademakers F, Pohost G, Lima JAC (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148CrossRefPubMedGoogle Scholar
  26. 26.
    Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos E, Panopoulos S, Bournia V, Manolopoulou D, Kolovou G, Kitas G (2014) Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block. Int J Cardiol 171:82–87CrossRefPubMedGoogle Scholar
  27. 27.
    Kobayashi Y, Kobayashi H, Giles JT, Hirano M, Nakajima Y, Takei M (2016) Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Int J Rheum Dis 19:1169–1174CrossRefPubMedGoogle Scholar
  28. 28.
    Mayr A, Kitterer D, Latus J, Steubing H, Henes J, Vecchio F, Kaesemann P, Patrascu A, Greiser A, Groeninger S, Braun N, Alscher MD, Sechtem U, Mahrholdt H, Greulich S (2016) Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:1–13Google Scholar
  29. 29.
    Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Kolovou G (2017) Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases. J Inflamm Res 10:55–61CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45(11):1815–1822CrossRefPubMedGoogle Scholar
  31. 31.
    Maceira AM, Monmeneu JV, Igual-Muñoz B, Lopez-Lereu PM, Garcia PM, Cosin J (2015) Reference values for regional and global myocardial T2 mapping with cardiovascular magnetic resonance at 1.5T and 3T. J Cardiovasc Magn Reson 17(Suppl 1):P12CrossRefPubMedCentralGoogle Scholar
  32. 32.
    Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P, International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 53(17):1475–1487CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ong P, Athansiadis A, Hill S, Kispert EM, Borgulya G, Klingel K, Kandolf R, Sechtem U, Mahrholdt H (2011) Usefulness of pericardial effusion as new diagnostic criterion for noninvasive detection of myocarditis. Am J Cardiol. 108:445–452CrossRefPubMedGoogle Scholar
  34. 34.
    Nathan M, Ying LC, Pierre C, Blumke D, Lima J (2011) Assessment of myocardial fibrosis with cardiac magnetic resonance. J Am Coll Cardiol 57(8):891–903CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98:1436–1441CrossRefPubMedGoogle Scholar
  36. 36.
    Schalla S, Nagel E, Lehmkuhl H, Klein C, Bornstedt A, Schnackenburg B et al (2001) Comparison of magnetic resonance real-time imaging of LV function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 87:95–99CrossRefPubMedGoogle Scholar
  37. 37.
    Bottini PB, Carr AA, Prisant M et al (1995) Magnetic resonance imaging compared to echo/phy to assess LV MASS in the hypertensive patient. Am J Hypertens 8:221–226CrossRefPubMedGoogle Scholar
  38. 38.
    Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148CrossRefPubMedGoogle Scholar
  39. 39.
    Chiribiri A, Botnar RM, Nagel E (2013) Magnetic resonance coronary angiography: where are we today? Curr Cardiol Rep 15(2):328CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM (2009) Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum 61(8):1121–1129CrossRefPubMedGoogle Scholar
  41. 41.
    Terashima M, Nguyen PK, Rubin GD, Meyer CH, Shimakawa A, Nishimura DG, Ehara S, Iribarren C, Courtney BK, Go AS, Hlatky MA, Fortmann SP, McConnell MV (2010) Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J Cardiovasc Magn Reson 12:75CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH (2007) Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 115(2):228–235CrossRefPubMedGoogle Scholar
  43. 43.
    Schwitter J (2006) Myocardial perfusion imaging by cardiac magnetic resonance. J Nucl Cardiol 13:841–854 (21) CrossRefPubMedGoogle Scholar
  44. 44.
    Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, Marincek B, Luscher TF, von Schulthess GK (2001) Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103:2230–2235CrossRefPubMedGoogle Scholar
  45. 45.
    Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S (2007) Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med 58:777–785CrossRefPubMedGoogle Scholar
  46. 46.
    Gebker R, Jahnke C, Paetsch I, Kelle S, Schnackenburg B, Fleck E, Nagel E (2008) Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease. Radiology 247:57–63CrossRefPubMedGoogle Scholar
  47. 47.
    Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379:453–460CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Gargiulo P, Dellegrottaglie S, Bruzzese D, Savarese G, Scala O, Ruggiero D, D’Amore C, Paolillo S, Agostoni P, Bossone E, Soricelli A, Cuocolo A, Trimarco B, Filardi PP (2013) The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis. Circ Cardiovasc Imaging 6(4):574–582CrossRefPubMedGoogle Scholar
  49. 49.
    Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT (2017) Magnetic resonance imaging-detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N-terminal Pro-brain natriuretic peptide levels. Arthritis Care Res (Hoboken) 69(9):1304–1311CrossRefGoogle Scholar
  50. 50.
    Holmström M, Koivuniemi R, Korpi K, Kaasalainen T, Laine M, Kuuliala A, Leirisalo-Repo M, Kupari M, Kivistö S (2016) Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis. Clin Exp Rheumatol 34(3):416–423PubMedGoogle Scholar
  51. 51.
    Mavrogeni S, Bratis K, Koutsogeorgopoulou L, Karabela G, Savropoulos E, Katsifis G, Raftakis J, Markousis-Mavrogenis G, Kolovou G (2017) Myocardial perfusion in peripheral Raynaud’s phenomenon. Evaluation using stress cardiovascular magnetic resonance. Int J Cardiol 228:444–448CrossRefPubMedGoogle Scholar
  52. 52.
    Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 18(8):891–975CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Sophie Mavrogeni
    • 1
    • 4
  • Lambros Fotis
    • 2
  • Loukia Koutsogeorgopoulou
    • 3
  • Vasiliki Vartela
    • 4
  • Vana Papaevangelou
    • 2
  • Genovefa Kolovou
    • 1
  1. 1.Onassis Cardiac Surgery CenterAthensGreece
  2. 2.Attikon HospitalAthensGreece
  3. 3.Laikon HospitalAthensGreece
  4. 4.AthensGreece

Personalised recommendations